Oocyte Retrieval and Virtual Reality (REVPO) (REVPO)
Primary Purpose
Oocyte Retrieval, Pain, Fertilization in Vitro
Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Hypnotic relaxation induced by virtual reality (device)
local anesthesia
Sponsored by

About this trial
This is an interventional treatment trial for Oocyte Retrieval focused on measuring Reproductive Techniques, Assisted, Oocyte retrieval, Virtual reality, Medically Assisted Procreation, Pain, Analgesia
Eligibility Criteria
Inclusion Criteria:
- Aged between 18 and 43 years
- First attempt of oocyte retrieval under local anesthesia in the context of a protocol for Medically Assisted Procreation
Exclusion Criteria:
- Former attempt of oocyte retrieval
- Poor oocyte stock : > 40 years AND low markers (AMH < 0.5-1.1 ng/ml OR AFC < 5-7)
- Unsteady epilepsia
Sites / Locations
- CHU de Clermont-FerrandRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Virtual Reality Group
Standard Group
Arm Description
in this group, patients will use virtual reality during the oocyte retrieval plus the standard anesthesic procedure (local anesthesia)
in this group, patients will receive the standard anesthesic procedure during the oocyte retrieval wich is local anesthesia
Outcomes
Primary Outcome Measures
Pain during oocyte retrieval, assessed by NRS
Oral evaluation of pain during the intervention for oocyte retrieval, evaluated by a Numeric Rating Scale (NRS) : from 0 (meaning no pain at all) to 10 (meaning worse pain possible).
Secondary Outcome Measures
Pain after oocyte retrieval, assessed by NRS
Written evaluation of pain after the intervention for oocyte retrieval, evaluated by a Numeric Rating Scale (NRS) : from 0 (meaning no pain at all) to 10 (meaning worse pain possible).
Painkillers consumption during the 48 hours following the oocyte retrieval.
Written auto-evaluation (questionnaire) of the amount and type of painkillers taken by the patient during the 48hours following the intervention
Patient satisfaction concerning the use of virtual reality during the oocyte retrieval
Written evaluation of the patient global satisfaction concerning the virtual reality during the oocyte retrieval. (2 questions : "Concerning the use of virtual reality during the oocyte retrieval, are you : very satisfied, little satisfied, not satisfied, not at all satisfied"; "if you had to re-take an oocyte retrieval, would you : do it again with virtual reality, do it again without virtual reality, do it under general anesthesia")
Gynaecologist satisfaction concerning the use of virtual reality during the oocyte retrieval
Written evaluation of the gynaecologist satisfaction concerning the use of virtual reality during the oocyte retrieval (4 questions : "Concerning the security during the oocyte retrieval, are you very satisfied, little satisfied, not satisfied, not at all satisfied", "Concerning the easiness of the oocyte retrieval, are you very satisfied, little satisfied, not satisfied, not at all satisfied", "During the oocyte retrieval, the patient seemed : very relaxed, relaxed, not relaxed, not at relaxed"; "as a whole, if this patient should re-take an oocyte retrieval, ould you recommend the use of virtual reality? Yes/No, can you tell us why in a few words")
Efficacy of the use of virtual reality during oocyte retrieval
Ratio between the number of oocytes collected during the retrieval compared to the number of oocytes expected on the ultrasound monitoring
Full Information
NCT ID
NCT04935658
First Posted
May 25, 2021
Last Updated
June 12, 2023
Sponsor
University Hospital, Clermont-Ferrand
1. Study Identification
Unique Protocol Identification Number
NCT04935658
Brief Title
Oocyte Retrieval and Virtual Reality (REVPO)
Acronym
REVPO
Official Title
Study of Analgesic Effect of Virtual Reality During Oocyte Retrieval in In Vitro Fecondation Protocols: Controlled Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 9, 2021 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to ass wether or not the use of virtual reality during oocyte retrieval provides a better pain relief for patients, compared to a standard analgesic procedure.
Detailed Description
Patients will be included during the consultation with the gynaecologist, whom will explain the protocol to the patient and give her the consent to sign.
The patient will be then randomized by a computer (using the software REDCAP) into either the experimental group or the standard group.
In the experimental group, a virtual reality device will be installed on the patient as soon as she arrives in the operating room, and the intervention will start after 3-5 minutes.
In both group, the patient will benefit of a local anesthesia in the vagina, and if they want it of an oral analgesic before the intervention.
Just at the end of the intervention, the pain will be evaluated orally by the nurse, using a Numeric Rating Scale. This consist of the Primary Outcome.
After the intervention, the gynaecologist will fill a form assessing his satisfaction concerning the use of virtual reality during the intervention (efficacy, security...) One hour after the intervention, the patient will fill a form about her self-estimation of the post-procedural pain and her satisfaction concerning the use of virtual reality.
The number of oocytes collected and the number of oocytes expected on the ultrasound monitoring will be gathered and a ratio will be calculated, in order to estimate the efficacy of the retrieval.
Five days after the intervention, the patient will have to fill a form evaluating her consumption of painkillers during the 48hours following the intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oocyte Retrieval, Pain, Fertilization in Vitro
Keywords
Reproductive Techniques, Assisted, Oocyte retrieval, Virtual reality, Medically Assisted Procreation, Pain, Analgesia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
participants receive an intervention throughout the protocol
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Virtual Reality Group
Arm Type
Experimental
Arm Description
in this group, patients will use virtual reality during the oocyte retrieval plus the standard anesthesic procedure (local anesthesia)
Arm Title
Standard Group
Arm Type
Sham Comparator
Arm Description
in this group, patients will receive the standard anesthesic procedure during the oocyte retrieval wich is local anesthesia
Intervention Type
Device
Intervention Name(s)
Hypnotic relaxation induced by virtual reality (device)
Intervention Description
A virtual reality device will be install on the patient 3-5 minutes before the beginning of the oocyte retrieval. The device will be wearing by the patient during the entire intervention and 2 minutes after the end of the ponction.
Intervention Type
Drug
Intervention Name(s)
local anesthesia
Intervention Description
standard anesthesic procedure
Primary Outcome Measure Information:
Title
Pain during oocyte retrieval, assessed by NRS
Description
Oral evaluation of pain during the intervention for oocyte retrieval, evaluated by a Numeric Rating Scale (NRS) : from 0 (meaning no pain at all) to 10 (meaning worse pain possible).
Time Frame
day 0 (During the intervention for oocyte retrieval)
Secondary Outcome Measure Information:
Title
Pain after oocyte retrieval, assessed by NRS
Description
Written evaluation of pain after the intervention for oocyte retrieval, evaluated by a Numeric Rating Scale (NRS) : from 0 (meaning no pain at all) to 10 (meaning worse pain possible).
Time Frame
hour 1 (In the hour following the oocyte retrival)
Title
Painkillers consumption during the 48 hours following the oocyte retrieval.
Description
Written auto-evaluation (questionnaire) of the amount and type of painkillers taken by the patient during the 48hours following the intervention
Time Frame
Day 5
Title
Patient satisfaction concerning the use of virtual reality during the oocyte retrieval
Description
Written evaluation of the patient global satisfaction concerning the virtual reality during the oocyte retrieval. (2 questions : "Concerning the use of virtual reality during the oocyte retrieval, are you : very satisfied, little satisfied, not satisfied, not at all satisfied"; "if you had to re-take an oocyte retrieval, would you : do it again with virtual reality, do it again without virtual reality, do it under general anesthesia")
Time Frame
hour 1 (In the hour following the oocyte retrival)
Title
Gynaecologist satisfaction concerning the use of virtual reality during the oocyte retrieval
Description
Written evaluation of the gynaecologist satisfaction concerning the use of virtual reality during the oocyte retrieval (4 questions : "Concerning the security during the oocyte retrieval, are you very satisfied, little satisfied, not satisfied, not at all satisfied", "Concerning the easiness of the oocyte retrieval, are you very satisfied, little satisfied, not satisfied, not at all satisfied", "During the oocyte retrieval, the patient seemed : very relaxed, relaxed, not relaxed, not at relaxed"; "as a whole, if this patient should re-take an oocyte retrieval, ould you recommend the use of virtual reality? Yes/No, can you tell us why in a few words")
Time Frame
hour 1 (In the hour following the oocyte retrival)
Title
Efficacy of the use of virtual reality during oocyte retrieval
Description
Ratio between the number of oocytes collected during the retrieval compared to the number of oocytes expected on the ultrasound monitoring
Time Frame
hour 1 (In the hour following the oocyte retrival)
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
43 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged between 18 and 43 years
First attempt of oocyte retrieval under local anesthesia in the context of a protocol for Medically Assisted Procreation
Exclusion Criteria:
Former attempt of oocyte retrieval
Poor oocyte stock : > 40 years AND low markers (AMH < 0.5-1.1 ng/ml OR AFC < 5-7)
Unsteady epilepsia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lise LACLAUTRE
Phone
+33473754963
Email
promo_interne_drci@chu-clermontferrand.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Camille Valdeyron
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lise Laclautre
Phone
+33473754963
Email
promo_interne_drci@chu-clermontferrand.fr
First Name & Middle Initial & Last Name & Degree
Camille Valdeyron
First Name & Middle Initial & Last Name & Degree
Florence Brugnon
12. IPD Sharing Statement
Learn more about this trial
Oocyte Retrieval and Virtual Reality (REVPO)
We'll reach out to this number within 24 hrs